• ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Search
EUCAST
menu
Back Close
  • About EUCAST
    About EUCAST
    • Overview
    Close
    Organisation
    • Overview
    • Steering Committee
    • General Committee
    • EUCAST Statutes
    • National AST Committees (NAC)
      • Overview
      • Join NACs Network
    • Network Laboratories
    • Development Laboratories (EDL)
    • View all
    Subcommittees
    • Overview
    • Antimycobacterial Susceptibility Testing (AMST)
    • Antifungal Susceptibility Testing (AFST)
    • Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST)
    • Phage Susceptibility Testing Subcommittee (PST)
    • Subcommittee on WGS and Phenotypic AST
    • View all
    Meetings
    • Overview
    • Steering Committee Meetings
    • General Committee Meetings
    Public Consultations
    • Overview
    SOPs
    • Overview
    IVDR and EUCAST
    • Overview
    News
    • Overview
    Publications and Presentations
    • Overview
  • Bacteria
    Bacteria
    • Overview
    Close
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical Breakpoint Tables
    • Definition of S, I and R
    • When there are no breakpoints?
    • Breakpoints in Brackets
    Guidance Documents
    • Overview
    Important Additional Information
    • Overview
    • Expert Rules
    • Expected Phenotypes
    • Resistance Detection
    MIC and Zone Distributions, ECOFFs
    • Overview
    Methodology and Instructions
    • Overview
    • Disk Diffusion and Quality Control
    • MIC Determination
    • Warnings
    • Media Preparation
    • Disk Diffusion Implementation
    • EUCAST Panels of Phenotypically Defined Strains
      • Overview
      • EUCAST Panel of S. pneumoniae and betalactam agents
      • EUCAST Panel of nine well characterized P. aeruginosa strains
    • IVDR and EUCAST
    • View all
    Rapid AST in blood culture
    • Overview
    • Rapid AST directly from blood culture bottles
    • Methods and Quality Control
    • Breakpoints for Rapid AST
    • Resistance Detection in RAST
    • RAST FAQ
    • RAST MIC:zone diameter correlations
    • RAST Publications
    • View all
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • About Clinical Breakpoints
    • Setting Breakpoints
    • Public Consultations
    • Rationale Documents
    • MIC:Zone Diameter correlations
    • Technical Notes on Antibacterial Agents
    • View all
    FAQ and EDL Services
    • Overview
    • FAQ
    • EDL MIC Testing Services
  • Mycobacteria (AMST)
    Mycobacteria (AMST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of Clinical Breakpoints and ECOFFs
    • Overview
    • Public Consultations
    • Rationale Documents
    Methodology and Instructions
    • Overview
    • Reference Method
    • Mycobacteria FAQ
    • Warnings
    • IVDR and EUCAST
    Publications and Presentations
    • Overview
  • Fungi (AFST)
    Fungi (AFST)
    • Overview
    Close
    Subcommittee
    • Overview
    Clinical Breakpoints and Interpretation
    • Overview
    • Clinical breakpoint table
    • When there are no antifungal breakpoints
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale documents
    • Public consultations
    Methodology and Instructions
    • Overview
    • AST of Yeasts
    • AST of Moulds
    • AST of Dermatophytes
    • Warnings
    • Quality Control
    • IVDR and EUCAST
    • View all
    Publications and Presentations
    • Overview
    • Technical Notes on Antifungal Agents
  • VetCAST
    VetCAST
    • Overview
    Close
    Subcommittee
    • Overview
    MIC distributions and ECOFFs
    • Overview
    Development of clinical breakpoints and ECOFFs
    • Overview
    • Rationale Documents
    Publications and presentations
    • Overview
  • Industry
    Industry
    • Overview
    Close
  • Education
    Education
    • Overview
    Close
Search
  • ESCMID
  • CMI
  • EUCAST Newsletter
  • EUCAST News
Frequent searches
  • breakpoints
  • rationale documents
  • expected phenotypes
  • public consultation
  • endocarditis pathogens
  • guidance documents
Suggestions
  1. Home
  2. Search

Search Results

General

Information for industry - reference and standardised AST.

EUCAST guidance on how to determine MIC values and develop distributions (and zone diameter distributions) for new agents in preparation for EUCAST and EMA evaluation. The development of new agents requires agreement and acceptance of the data generated in support of decisions on clinical…

Get to know more

General Committee Meetings

General Committee Meetings The EUCAST yearly General Committee meetings are open meetings, held during yearly ESCMID-Global conferences. Everyone interested in breakpoints and AST methods are welcome. Meeting minutes EUCAST General Committee meeting 2024 (ECCMID, Barcelona) EUCAST General Committee…

Get to know more

S, I and R and surveillance of AMR

This is to clarify how "susceptibility (S and I)" and "resistance (R)" should be reported in AMR surveillance with the EUCAST definitions of S I and R . With the EUCAST definitions, the tradition to report "non-susceptibility" as the joint rate of %I and %R is abandoned. Previously (pre-2019) it was…

Get to know more

Resistance Detection in RAST

Resistance Detection in RAST Some resistance mechanisms require other than clinical breakpoints for sensitive detection. EUCAST has validated using separate screening cut-offs for the detection of E. coli and K. pneumoniae with ESBL or carbapenemases. Screening for resistance mechanisms using RAST…

Get to know more

MIC and Zone Distributions, ECOFFs

The database of MIC and zone diameter distributions was created by Gunnar Kahlmeter for EUCAST from 2002 and onwards. More data is regularly added and all data is curated by Gunnar Kahlmeter and John Turnidge. The website gives MIC distributions and inhibition zone diameter distributions for…

Get to know more

Is there a EUCAST alternative to MH-F for AST of fastidious organisms?

Susceptibility testing of fastidious organisms - is there an alternative to MH-F ? Public consultation 2025-06-19 - 08-29. The EUCAST medium MH-F was developed for AST of fastidious organisms.Colleagues in some areas of the world have difficulties obtaining the MH-F plate based on horse blood. The…

Get to know more

EUCAST aphorisms

The manufacturer of antimicrobial susceptibility testing material is responsible for the quality of the material provided to microbiological laboratories. The laboratory is responsible for the result provided to doctors and patients. To perform AST where there is intrinsic resistance is wasting the…

Get to know more

How to make use of EUCAST MIC and zone distributions

EUCAST distributions of MIC and Zone diameters (https:/mic.eucast.org; choose either “MIC” or “Disk diffusion”) are freely available. When sufficiently many acceptable distributions are available to the curators, ECOFFs are determined and listed beneath each graph together with confidence intervals.…

Get to know more

Rationale documents

Rationale documents Amphotericin B v 3.0 (26 June 2025) Anidulafungin vs. Candida v 5.0 (26 June 2025) Caspofungin vs Candida - there is no caspofungin RD and no specific caspofungin breakpoints. Use anidulafungin and micafungin as markers for caspofungin susceptibility where isolates "S" to both…

Get to know more

Seminar on EUCAST Disk diffusion of anaerobic bacteria 9 December

Disk diffusion of anaerobic bacteria in 16-20 hours (9 December, 2021; at 8AM , 1PM and 4PM CET to satisfy different time zones; link below). EUCAST has developed a disk diffusion method for AST of 5 anaerobic species (Bacteroides spp, Prevotella spp, Fusobacterium necrophorum, Clostridium…

Get to know more
Show more results
© EUCAST 2026. All rights reserved EUCAST.
ContactSitemapPrivacy NoticeDisclaimerCookies